Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search Results for: aacc

CPI Lab Fee Adjustment Threatened by New Bill

CEO SUMMARY: Once again, the laboratory testing industry has been singled out as a healthcare “whipping boy” by Congressional aides. In working to develop the next federal budget, legislators again propose to deny annual CPI price updates for laboratory tests. This won’t be anything new, since only once in 14 years has Congress funded a …

CPI Lab Fee Adjustment Threatened by New Bill Read More »

To access this post, you must purchase The Dark Report.

Institute of Medicine Calls For 12 Medicare Lab Reforms

CEO SUMMARY: Since 1987, the clinical lab industry has endured almost non-stop cuts in the absolute level of Medicare reimbursement for lab testing. But the time may be ripe for laboratories to work together to effect far-reaching reforms to Medicare laboratory payment policies. Just as the Institute of Medicine issued its 12 recommendations for reforming …

Institute of Medicine Calls For 12 Medicare Lab Reforms Read More »

To access this post, you must purchase The Dark Report.

“March 19, 2001 Intelligence: Late Breaking Lab News”

It’s one more market sign of the continuing turmoil still transforming the traditional healthcare marketplace. New numbers reveal another decline in the membership of the American Medical Association (AMA). During 2000, the AMA lost 3,000 physician members. Only 290,357 physicians, or 32%, of the nation’s 901,147 physicians retain AMA membership. More significantly, at least 82,000 …

“March 19, 2001 Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

“October 23, 2000 Intelligence: Late Breaking Lab News”

Get ready for the stock market to begin creating multi-millionaires from today’s generation of commercial laboratory executives. Most laboratorians know that Roche sold $430.5 million of its stock holding in Laboratory Corporation of America stock only seven days ago. Lesser known is the fact that LabCorp executives Thomas McMahon and Brad Smith sold a total …

“October 23, 2000 Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

Dr. Bruce Friedman Identifies Market Dynamics Driving Evolution of Lab Information Services

CEO SUMMARY: Probably no one is better positioned to identify the evolution of laboratory information services than Bruce Friedman, M.D., Professor of Pathology at the University of Michigan Medical School in Ann Arbor. For almost 20 years, he has hosted the pre-eminent meeting in laboratory informatics, known as AIMCL—Automated Information Management for Clinical Laboratories. Dr. …

Dr. Bruce Friedman Identifies Market Dynamics Driving Evolution of Lab Information Services Read More »

To access this post, you must purchase The Dark Report.

“March 6, 2000 Intelligence: Late Breaking Lab News”

Interesting things are afoot at Esoterix, Inc., the Austin, Texas-based parent company for six specialty laboratories. President and CEO Charles L Dufesche, M.D. recently left. The new CEO is James McClintic. Esoterix has plans to become a public company and has been shopping its IPO (initial public offering) among brokerage houses. Calls to Esoterix went …

“March 6, 2000 Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

New Blood Entering the Lab Industry

SURPRISE! THERE’S A QUIET MANAGEMENT REVOLUTION UNDER WAY in both the clinical laboratory industry and pathology profession. During the past few years, a steady flow of new-thinking Presidents and CEOs have taken control of laboratories, pathology group practices, and vendor companies. From CEO Ken Freeman of Quest Diagnostics Incorporated to CEO James New of AmeriPath, …

New Blood Entering the Lab Industry Read More »

To access this post, you must purchase The Dark Report.

Movers & Shakers For ’99 Demonstrate Leadership

EACH YEAR IT BECOMES more difficult to make final selections for our annual Movers & Shakers awards. The reason is simple. Today there are more examples of leadership in the laboratory than when we first started these selections three years ago. This is a good omen. It means that the crucible of the marketplace is …

Movers & Shakers For ’99 Demonstrate Leadership Read More »

To access this post, you must purchase The Dark Report.

Bayer Acquires Chiron In Consolidation Move

CEO SUMMARY: As expected, consolidation within the diagnostics industry continues. This time it is Bayer, spending $1.1 billion to acquire Chiron’s diagnostics business. Once completed, Bayer will be the fourth-largest diagnostics company in the world. Laboratory customers of both firms will see many changes during the 18 months following the merger. ONCE AGAIN THE DIAGNOSTICS …

Bayer Acquires Chiron In Consolidation Move Read More »

To access this post, you must purchase The Dark Report.

;